Skip to Content
Merck
All Photos(1)

Documents

Y0002042

Etanercept BRP

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Etanercept

Sign Into View Organizational & Contract Pricing


About This Item

CAS Number:
UNSPSC Code:
41116107
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

etanercept

manufacturer/tradename

EDQM

application(s)

pharmaceutical

format

neat

storage temp.

−20°C

Looking for similar products? Visit Product Comparison Guide

General description

Etanercept is a tumor necrosis factor (TNF) antagonist that acts by binding with TNF cytokine or protein, thereby blocking its interaction with cell surface receptors. This dimeric fusion protein consists of 934 amino acids with a molecular mass of ~150KDa.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

This European Pharmacopoeia reference standard is intended for use only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

Product No.
Description
Pricing

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Etanercept: An overview
Goffe B and Cather JC
Journal of the American Academy of Dermatology, 49(2), 105-111 (2003)
Rheumatiod Arthritis: An Updated Overview of Latest Therapy and Drug Delivery
Kesharwani D, et al.
Journal of pharmacopuncture, 22(4), 210-224 (2019)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service